:
Case Ⅰ: 3DMed: An R&D Platform for Personalised Precision
Anti-cancer Drugs
Overview of Anti-cancer Drug R&D
History of Anti-cancer Drug R&D
From R&D to Launch
The Biopharmaceutical Industry Chain
Analysis of Global Market Potential
Analysis of Chinese Market Potential
The Start-Up Decision
The Early Years: Accumulating Knowledge
Forecast of Market Trends
Back to the Homeland
The Start-Up‘s Focus
Individualised Precision Treatment
Large-Scale Drug Screening Model
Next-Generation Sequencing (NGS)
Big Data Processing
The Start-Up Process
Founding the Company
The Entrepreneurial Team
Accumulating Resources
Angel Round of Financing
Technological In
...